Effects of pluronic P85 on GLUT1 and MCT1 transporters in the blood-brain barrier

Elena V. Batrakova, Yan Zhang, Yili Li, Shu Li, Sergei V. Vinogradov, Y. Persidsky, Valery Yu Alakhov, Donald W. Miller, Alexander V. Kabanov

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Purpose. The amphiphilic block copolymer Pluronic P85 (P85) increases the permeability of the blood-brain barrier (BBB) with respect to a broad spectrum of drugs by inhibiting the drug efflux transporter, P-glycoprotein (Pgp). In this regard, P85 serves as a promising component for CNS drug delivery systems. To assess the possible effects of P85 on other transport systems located in the brain, we examined P85 interactions with the glucose (GLUT1) and monocarboxylate (MCT1) transporters. Methods. Polarized monolayers of primary cultured bovine brain microvessel endothelial cells (BBMEC) were used as an in vitro model of the BBB. 3H-2-deoxy-glucose and 14C-lactate were selected as GLUT1 and MCT1 substrates, respectively. The accumulation and flux of these substrates added to the luminal side of the BBMEC monolayers were determined. Results. P85 has little effect on 3H-2-deoxy-glucose transport. However, a significant decrease 14C-lactate transport across BBMEC monolayers is observed. Histology, immunohistochemistry, and enzyme histochemistry studies show no evidence of P85 toxicity in liver, kidney, and brain in mice. Conclusions. This study suggests that P85 formulations do not interfere with the transport of glucose. This is, probably, due to compensatory mechanisms in the BBB. Regarding the transport of monocarboxylates, P85 formulations might slightly affect their homeostasis in the brain, however, without any significant toxic effects.

Original languageEnglish (US)
Pages (from-to)1993-2000
Number of pages8
JournalPharmaceutical Research
Volume21
Issue number11
DOIs
StatePublished - Dec 1 2004

Fingerprint

Poloxamer
Blood-Brain Barrier
Brain
Endothelial cells
Microvessels
Glucose
Monolayers
Endothelial Cells
Lactic Acid
Histology
Poisons
P-Glycoprotein
Substrates
Drug Delivery Systems
Pharmaceutical Preparations
Liver
Toxicity
Permeability
Homeostasis
Immunohistochemistry

Keywords

  • Blood-brain barrier
  • Glucose
  • Metabolism
  • Monocarboxylates
  • Pluronic

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry
  • Pharmacology (medical)

Cite this

Batrakova, E. V., Zhang, Y., Li, Y., Li, S., Vinogradov, S. V., Persidsky, Y., ... Kabanov, A. V. (2004). Effects of pluronic P85 on GLUT1 and MCT1 transporters in the blood-brain barrier. Pharmaceutical Research, 21(11), 1993-2000. https://doi.org/10.1023/B:PHAM.0000048189.79606.6e

Effects of pluronic P85 on GLUT1 and MCT1 transporters in the blood-brain barrier. / Batrakova, Elena V.; Zhang, Yan; Li, Yili; Li, Shu; Vinogradov, Sergei V.; Persidsky, Y.; Alakhov, Valery Yu; Miller, Donald W.; Kabanov, Alexander V.

In: Pharmaceutical Research, Vol. 21, No. 11, 01.12.2004, p. 1993-2000.

Research output: Contribution to journalArticle

Batrakova, EV, Zhang, Y, Li, Y, Li, S, Vinogradov, SV, Persidsky, Y, Alakhov, VY, Miller, DW & Kabanov, AV 2004, 'Effects of pluronic P85 on GLUT1 and MCT1 transporters in the blood-brain barrier', Pharmaceutical Research, vol. 21, no. 11, pp. 1993-2000. https://doi.org/10.1023/B:PHAM.0000048189.79606.6e
Batrakova, Elena V. ; Zhang, Yan ; Li, Yili ; Li, Shu ; Vinogradov, Sergei V. ; Persidsky, Y. ; Alakhov, Valery Yu ; Miller, Donald W. ; Kabanov, Alexander V. / Effects of pluronic P85 on GLUT1 and MCT1 transporters in the blood-brain barrier. In: Pharmaceutical Research. 2004 ; Vol. 21, No. 11. pp. 1993-2000.
@article{605d444cc7db478f8498d6ed61a74757,
title = "Effects of pluronic P85 on GLUT1 and MCT1 transporters in the blood-brain barrier",
abstract = "Purpose. The amphiphilic block copolymer Pluronic P85 (P85) increases the permeability of the blood-brain barrier (BBB) with respect to a broad spectrum of drugs by inhibiting the drug efflux transporter, P-glycoprotein (Pgp). In this regard, P85 serves as a promising component for CNS drug delivery systems. To assess the possible effects of P85 on other transport systems located in the brain, we examined P85 interactions with the glucose (GLUT1) and monocarboxylate (MCT1) transporters. Methods. Polarized monolayers of primary cultured bovine brain microvessel endothelial cells (BBMEC) were used as an in vitro model of the BBB. 3H-2-deoxy-glucose and 14C-lactate were selected as GLUT1 and MCT1 substrates, respectively. The accumulation and flux of these substrates added to the luminal side of the BBMEC monolayers were determined. Results. P85 has little effect on 3H-2-deoxy-glucose transport. However, a significant decrease 14C-lactate transport across BBMEC monolayers is observed. Histology, immunohistochemistry, and enzyme histochemistry studies show no evidence of P85 toxicity in liver, kidney, and brain in mice. Conclusions. This study suggests that P85 formulations do not interfere with the transport of glucose. This is, probably, due to compensatory mechanisms in the BBB. Regarding the transport of monocarboxylates, P85 formulations might slightly affect their homeostasis in the brain, however, without any significant toxic effects.",
keywords = "Blood-brain barrier, Glucose, Metabolism, Monocarboxylates, Pluronic",
author = "Batrakova, {Elena V.} and Yan Zhang and Yili Li and Shu Li and Vinogradov, {Sergei V.} and Y. Persidsky and Alakhov, {Valery Yu} and Miller, {Donald W.} and Kabanov, {Alexander V.}",
year = "2004",
month = "12",
day = "1",
doi = "10.1023/B:PHAM.0000048189.79606.6e",
language = "English (US)",
volume = "21",
pages = "1993--2000",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "Springer New York",
number = "11",

}

TY - JOUR

T1 - Effects of pluronic P85 on GLUT1 and MCT1 transporters in the blood-brain barrier

AU - Batrakova, Elena V.

AU - Zhang, Yan

AU - Li, Yili

AU - Li, Shu

AU - Vinogradov, Sergei V.

AU - Persidsky, Y.

AU - Alakhov, Valery Yu

AU - Miller, Donald W.

AU - Kabanov, Alexander V.

PY - 2004/12/1

Y1 - 2004/12/1

N2 - Purpose. The amphiphilic block copolymer Pluronic P85 (P85) increases the permeability of the blood-brain barrier (BBB) with respect to a broad spectrum of drugs by inhibiting the drug efflux transporter, P-glycoprotein (Pgp). In this regard, P85 serves as a promising component for CNS drug delivery systems. To assess the possible effects of P85 on other transport systems located in the brain, we examined P85 interactions with the glucose (GLUT1) and monocarboxylate (MCT1) transporters. Methods. Polarized monolayers of primary cultured bovine brain microvessel endothelial cells (BBMEC) were used as an in vitro model of the BBB. 3H-2-deoxy-glucose and 14C-lactate were selected as GLUT1 and MCT1 substrates, respectively. The accumulation and flux of these substrates added to the luminal side of the BBMEC monolayers were determined. Results. P85 has little effect on 3H-2-deoxy-glucose transport. However, a significant decrease 14C-lactate transport across BBMEC monolayers is observed. Histology, immunohistochemistry, and enzyme histochemistry studies show no evidence of P85 toxicity in liver, kidney, and brain in mice. Conclusions. This study suggests that P85 formulations do not interfere with the transport of glucose. This is, probably, due to compensatory mechanisms in the BBB. Regarding the transport of monocarboxylates, P85 formulations might slightly affect their homeostasis in the brain, however, without any significant toxic effects.

AB - Purpose. The amphiphilic block copolymer Pluronic P85 (P85) increases the permeability of the blood-brain barrier (BBB) with respect to a broad spectrum of drugs by inhibiting the drug efflux transporter, P-glycoprotein (Pgp). In this regard, P85 serves as a promising component for CNS drug delivery systems. To assess the possible effects of P85 on other transport systems located in the brain, we examined P85 interactions with the glucose (GLUT1) and monocarboxylate (MCT1) transporters. Methods. Polarized monolayers of primary cultured bovine brain microvessel endothelial cells (BBMEC) were used as an in vitro model of the BBB. 3H-2-deoxy-glucose and 14C-lactate were selected as GLUT1 and MCT1 substrates, respectively. The accumulation and flux of these substrates added to the luminal side of the BBMEC monolayers were determined. Results. P85 has little effect on 3H-2-deoxy-glucose transport. However, a significant decrease 14C-lactate transport across BBMEC monolayers is observed. Histology, immunohistochemistry, and enzyme histochemistry studies show no evidence of P85 toxicity in liver, kidney, and brain in mice. Conclusions. This study suggests that P85 formulations do not interfere with the transport of glucose. This is, probably, due to compensatory mechanisms in the BBB. Regarding the transport of monocarboxylates, P85 formulations might slightly affect their homeostasis in the brain, however, without any significant toxic effects.

KW - Blood-brain barrier

KW - Glucose

KW - Metabolism

KW - Monocarboxylates

KW - Pluronic

UR - http://www.scopus.com/inward/record.url?scp=9644298995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9644298995&partnerID=8YFLogxK

U2 - 10.1023/B:PHAM.0000048189.79606.6e

DO - 10.1023/B:PHAM.0000048189.79606.6e

M3 - Article

C2 - 15587920

AN - SCOPUS:9644298995

VL - 21

SP - 1993

EP - 2000

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 11

ER -